# CUPR — Cuprina Holdings (Cayman) Ltd · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** CUPR  
**Sources:** 22  
**Published:** 2026-10-23  
**Canonical:** https://app.k3vl4r.com/research/deep-research-cupr-cuprina-holdings-cayman-ltd-catalysts-narrative-ris-8772

---

## Cuprina Holdings (Cayman) Ltd (CUPR) — Research Snapshot (as of 2026-10-23)

**Company context.** Cuprina is a Singapore-based biomedical/biotechnology company developing and commercializing wound-care products (under the MEDIFLY brand) as well as operating in infertility, medical waste recycling, and cosmeceuticals/travel healthcare. It trades on Nasdaq Capital Market under "CUPR" [[1]](https://finance.yahoo.com/healthcare/articles/cuprina-holdings-cayman-limited-announces-015500992.html)[[2]](https://markets.businessinsider.com/news/stocks/cuprina-holdings-cayman-limited-announces-pricing-of-4-97-million-public-offering-1036550071)[[19]](https://stockanalysis.com/stocks/cupr/). The most recent reported closing price was ~$1.88 on October 22, 2026, with a market capitalization in the range of ~$13.17M–$14.08M (sources vary slightly, e.g., [[16]](https://www.marketbeat.com/stocks/NASDAQ/CUPR/)[[18]](https://finance.yahoo.com/quote/CUPR/)[[19]](https://stockanalysis.com/stocks/cupr/) vs. the ~$14.08M figure noted in our background data).

---

### 1. Key Recent Catalysts (roughly July–October 2026)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-cupr-cuprina-holdings-cayman-ltd-catalysts-narrative-ris-8772 (free to sign up)._
